Sun safety showdown: experts unite to end confusion on sunscreen
NCT ID NCT07296588
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study brings together 15 dermatology experts to agree on the best sun protection practices for everyone, including children, pregnant women, and people with sun-sensitive skin. Using a structured method called Delphi, they will vote on recommendations about sunscreen use, clothing, and counseling. The goal is to reduce conflicting advice and provide clear, expert-backed guidance.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to clearer, evidence-based guidelines for sun protection tailored to different groups like children and pregnant women.
- What could go wrong
- This is a small expert consensus study, not a clinical trial testing a treatment. The recommendations may not reflect real-world outcomes or apply universally.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 15 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population will consist of a purposive sample of experts in dermatology, photobiology, and related fields who are actively involved in photoprotection research, clinical practice, or public health initiatives. Panelists should have experience advising patients or populations on sun protection, sunscreen use, and UV-related skin care. Panel Size and Rationale: Target enrollment: 20-35 experts Sufficient to capture diverse perspectives while remaining manageable for multiple Delphi rounds. Minimum for analysis: 15 panelists, ensuring representativeness in case of attrition
- Ages
-
25 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Board-certified dermatologists, photobiologists, or clinicians/researchers with ≥5 years of relevant experience. Regular involvement in advising on photoprotection, skin cancer prevention, or UV-related dermatology. Engagement in research, guideline development, teaching, or professional society activities related to dermatology, photobiology, or public health. Willingness and availability to participate in all Delphi rounds. Exclusion Criteria: * Non-dermatology or non-photobiology specialists without relevant experience. Less than 5 years of relevant clinical or research experience. Limited or no experience with photoprotection counseling or research. Significant undisclosed conflict of interest related to sunscreen or photoprotection products. Inability or unwillingness to participate in all Delphi rounds.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Photoprotection are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Venus Research Center
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.